Unknown

Dataset Information

0

Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking.


ABSTRACT: Leishmaniasis is a neglected vector-born disease caused by a protozoan of the genus Leishmania and affecting more than 1.300.000 people worldwide. The couple tryparedoxin/tryparedoxin peroxidase is essential for parasite survival in the host since it neutralizes the hydrogen peroxide produced by macrophages during the infection. Herein we report a study aimed at discovering the first class of compounds able to non-covalently inhibit tryparedoxin peroxidase. We have solved the high-resolution structure of Tryparedoxin peroxidase I from Leishmania major (LmTXNPx) in the reduced state and in fully folded conformation. A first series of compounds able to inhibit LmTXNPx was identified by means of the high throughput docking technique. The inhibitory activity of these compounds was validated by a Horseradish peroxidase-based enzymatic assay and their affinity for LmTXNPx calculated by surface plasmon resonance experiments. On the basis of these results, the analysis of the enzyme-inhibitor docked models allowed us to rationally design and synthesize a series of N,N-disubstituted 3-aminomethyl quinolones. These compounds showed an inhibitory potency against LmTXNPx in the micromolar range. Among them, compound 12 represents the first non-covalent LmTXNPx inhibitor reported to date and could pave the way to the discovery of a new class of drugs against leishmaniasis.

SUBMITTER: Brindisi M 

PROVIDER: S-EPMC4423475 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking.

Brindisi Margherita M   Brogi Simone S   Relitti Nicola N   Vallone Alessandra A   Butini Stefania S   Gemma Sandra S   Novellino Ettore E   Colotti Gianni G   Angiulli Gabriella G   Di Chiaro Francesco F   Fiorillo Annarita A   Ilari Andrea A   Campiani Giuseppe G  

Scientific reports 20150507


Leishmaniasis is a neglected vector-born disease caused by a protozoan of the genus Leishmania and affecting more than 1.300.000 people worldwide. The couple tryparedoxin/tryparedoxin peroxidase is essential for parasite survival in the host since it neutralizes the hydrogen peroxide produced by macrophages during the infection. Herein we report a study aimed at discovering the first class of compounds able to non-covalently inhibit tryparedoxin peroxidase. We have solved the high-resolution str  ...[more]

Similar Datasets

| S-EPMC3424247 | biostudies-literature
| S-EPMC6319256 | biostudies-literature
| S-EPMC7136196 | biostudies-literature
| S-EPMC4261743 | biostudies-literature
| S-EPMC3799847 | biostudies-literature
| S-EPMC4110426 | biostudies-literature
| S-EPMC1828487 | biostudies-literature
| S-EPMC8040153 | biostudies-literature
| S-EPMC3308743 | biostudies-literature
| S-EPMC3430366 | biostudies-literature